Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYSIF: Cyclosporine vs infliximab in steroid-refractory severe ulcerative colitis
2006-005299-42Phase 4Active
- Sponsor
- GETAID
- Start
- Mar 2007
- Modality
- Small Molecules, Peptides, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of cyclosporine, infliximab in autoimmune colitis, sponsored by GETAID. Started Mar 2007; status: active.
02
Drugs
cyclosporineinfliximab
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2006-005299-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005299-42.